This week's sponsor is Premier Research. | | Taking the Fight to Rare Cancers Beating rare cancers demands expertise in oncology and rare diseases. Our white paper shows how adaptive design, study committees, and cross-industry cooperation are fueling real progress. Premier Research. Built for biotech. | Today's Rundown Biogen, Eisai throw out remaining Alzheimer's BACE hope Amgen shares hit after analysts expose buried FDA trial halt Ritter's microbiome modulator fails lactose intolerance phase 3 [Sponsored] What Makes an Oncology Clinical Trial Site Stand Out from the Competition? Celgene's phase 3 AML test chalks up a win Pillar ponies up for Petri, Boston's new accelerator for fledgling biotechs EuroBiotech Report—Sanofi pays to scrap deal, BioNTech IPO, GSK takeover, Roche and 4BIO FiercePharmaAsia—BeiGene’s short attack; Sumitomo-Roivant deal; Roche-JHL settlement Chutes & Ladders—Bayer trims 2 execs in corporate reshuffling Featured Story | Friday, September 13, 2019 One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others. |
|
---|
| Top Stories Friday, September 13, 2019 Amgen Thursday posted what appeared to be a fairly innocuous update about its drug Kyprolis and other pipeline assets, but a deeper read turned up a nasty surprise. Friday, September 13, 2019 A phase 3 trial of Ritter Pharmaceuticals’ lactose intolerance prospect RP-G28 has missed its primary endpoint. The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms. Monday, September 9, 2019 Patients want the best cancer therapies, and sites that enable clinical trials are the ones that can access those new drugs faster. Here’s how Friday, September 13, 2019 A phase 3 trial of Celgene’s acute myeloid leukemia maintenance therapy CC-486 has met its primary endpoint. Patients who took the cytidine nucleoside analog lived longer than their peers on placebo. Friday, September 13, 2019 Boston-based Pillar is bankrolling a new accelerator for budding biotechs. Named Petri, the accelerator aims to serve a group left behind by life sciences- and health IT-focused VC firms—startups at the “frontier of biology and engineering.” Thursday, September 12, 2019 In this week's EuroBiotech Report, Sanofi pays $260 million to can Lexicon deal, BioNTech files for IPO and GSK buys celiac startup. Friday, September 13, 2019 BeiGene called allegations that it inflated drug sales numbers by 60% "wild speculations." Sumitomo Dainippon is paying $3 billion up front to pick up five of the "vant" biotechs. Likely to focus its legal power against individuals who allegedly stole trade secrets, Genentech has settled with JHL Biotech. And more. Friday, September 13, 2019 Bayer dumps two execs in corporate reshuffle; Coles to take over at Bayer spinoff Cerevel; Sanofi vet Jensen wins CMO spot at Vifor. Enrollment Showcase | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
---|
| Resources Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. U.S. Healthcare Compliance Certificate Program October 14-17, 2019 | Newark, New Jersey European Healthcare Compliance Certificate Program October 21-25, 2019 | Paris, France BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Immersion November 7-8, 2019 | Boston, MA Advanced Therapies: Immunotherapies, Cell Therapies and Gene Therapies November 15, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! |